Caddeo, A.; Kowalik, M.A.; Serra, M.; Runfola, M.; Bacci, A.; Rapposelli, S.; Columbano, A.; Perra, A.
TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD. Int. J. Mol. Sci. 2021, 22, 13105.
https://doi.org/10.3390/ijms222313105
AMA Style
Caddeo A, Kowalik MA, Serra M, Runfola M, Bacci A, Rapposelli S, Columbano A, Perra A.
TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD. International Journal of Molecular Sciences. 2021; 22(23):13105.
https://doi.org/10.3390/ijms222313105
Chicago/Turabian Style
Caddeo, Andrea, Marta Anna Kowalik, Marina Serra, Massimiliano Runfola, Andrea Bacci, Simona Rapposelli, Amedeo Columbano, and Andrea Perra.
2021. "TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD" International Journal of Molecular Sciences 22, no. 23: 13105.
https://doi.org/10.3390/ijms222313105
APA Style
Caddeo, A., Kowalik, M. A., Serra, M., Runfola, M., Bacci, A., Rapposelli, S., Columbano, A., & Perra, A.
(2021). TG68, a Novel Thyroid Hormone Receptor-β Agonist for the Treatment of NAFLD. International Journal of Molecular Sciences, 22(23), 13105.
https://doi.org/10.3390/ijms222313105